Since the result of the low predictive value of individual candidate biomarkers could be enhanced by combination [32–34], IDH1 was chosen to construct a panel to discriminate lung cancers as a candidate biomarker of the most common lung Ade. Here, IDH1 is linked to lung carcinoma.